Byetta (exenatide) is the first drug of a new group of antidiabetic drugs called incretin mimetics . It slows the emptying of the stomach after eating and has many of the effects of natural gut hormone GLP- 1.
Baie is administered to patients suffering from Type 2 insulin therapy with a sulphonylurea, metformin, or a combination of both , in which they can not attain the desired blood glucose values .
The preparation also suppresses appetite and slows the absorption of carbohydrates in the blood. Medicaments are administered by injection , twice a day. The main side effect of Byetta is nausea .
Byetta is used in patients with Type 2 insulin therapy with a sulphonylurea, metformin, or a combination of both, in which they can not attain the desired blood glucose values.